China Human Vaccine Market Research Report 2018

China Human Vaccine Market Research Report 2018

In the last several years, the market of China Human Vaccine changed greatly, with an average growth rate of -2.72% during 2013 to 2017. In 2017, revenue of China Human Vaccine is nearly 2478.15 M USD; the actual sale is about 552 M Dose.

The major players in China market include
CNBG
Changsheng Life
Zhifei
ChengDa Bio
Kangtai
SINOVAC BIOTECH
Hissen
Walvax Biotechnology
GSK
SANOFI
Rong An
NuoCheng Bio
Hualan Bio
Tiantan biological
Changchun Baike
Adimmune
Zhongyianke Biotech

Geographically, this report splits the China market into six regions,
South China
East China
Southwest China
Northeast China
North China
Central China
Northwest China

On the basis of product, the Human Vaccine market is primarily split into
Varicella
Influenza
Polio
Hepatitis A
Rabies
BCG
Hepatitis B
Pertussis, Diphtheria, Tetanus
Pneumococcal
Rota vaccine
Other

On the basis on the end users/applications, this report covers
Adults
Children


1 Human Vaccine Overview
1.1 Product Overview and Scope of Human Vaccine
1.2 Classification of Human Vaccine by Product Category
1.2.1 China Human Vaccine Sales Comparison by Types (2013-2025)
1.2.2 China Human Vaccine Sales Market Share by Types in 2017
1.2.3 Varicella
1.2.4 Influenza
1.2.5 Polio
1.2.6 Hepatitis A
1.2.7 Rabies
1.2.8 BCG
1.2.9 Hepatitis B
1.2.10 Pertussis, Diphtheria, tetanus
1.2.11 Pneumococcal
1.2.12 Rota Vaccine
1.3 China Human Vaccine Market by Applications/End Users
1.3.1 China Human Vaccine Sales and Market Share Comparison by Applications (2013-2025)
1.3.2 Adults
1.3.3 Children
1.4 China Human Vaccine Market by Regions
1.4.1 China Human Vaccine Market Size Comparison by Regions (2013-2025)
1.4.2 South China Human Vaccine Status and Prospect (2013-2025)
1.4.3 East China Human Vaccine Status and Prospect (2013-2025)
1.4.4 Southwest China Human Vaccine Status and Prospect (2013-2025)
1.4.5 Northeast China Human Vaccine Status and Prospect (2013-2025)
1.4.6 North China Human Vaccine Status and Prospect (2013-2025)
1.4.7 Central China Human Vaccine Status and Prospect (2013-2025)
1.4.8 Northwest China Human Vaccine Status and Prospect (2013-2025)
1.5 China Market Size (Sales and Revenue) of Human Vaccine (2013-2025)
1.5.1 China Human Vaccine Sales and Growth Rate (%) (2013-2025)
1.5.2 China Human Vaccine Revenue and Growth Rate (2013-2025)
2 China Human Vaccine Market Competition by Players/Manufacturers
2.1 China Human Vaccine Sales and Market Share of Key Players/Manufacturers (2017-2018)
2.2 China Human Vaccine Revenue and Share by Players/Manufacturers (2017-2018)
2.3 China Human Vaccine Average Price by Players/Manufacturers (2013-2018)
2.4 China Human Vaccine Market Competitive Situation and Trends
2.4.1 China Human Vaccine Market Concentration Rate
2.4.2 China Human Vaccine Market Share of Top 5 and Top 10 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in China Market
2.5 China Players/Manufacturers Human Vaccine Headquarters and Established Data
3 China Human Vaccine Sales and Revenue by Regions (2013-2018)
3.1 China Human Vaccine Sales and Market Share by Regions (2013-2018)
3.2 China Human Vaccine Revenue and Market Share by Regions (2013-2018)
3.3 China Human Vaccine Price by Regions (2013-2018)
4 China Human Vaccine Sales and Revenue by Type/ Product Category (2013-2018)
4.1 China Human Vaccine Sales and Market Share by Type/ Product Category (2013-2018)
4.2 China Human Vaccine Revenue and Market Share by Type (2013-2018)
4.3 China Human Vaccine Price by Type (2013-2018)
4.4 China Human Vaccine Sales Growth Rate by Type (2013-2018)
5 China Human Vaccine Sales by Application (2013-2018)
5.1 China Human Vaccine Sales and Market Share by Applications (2013-2018)
5.2 China Human Vaccine Sales Growth Rate by Applications (2013-2018)
6 Analysis of Human Vaccine Industry Key Manufacturers
6.1 CNBG
6.1.1 Company Profile
6.1.2 Product Information
6.1.3 Sales, Price, Revenue and Gross Margin
6.2 Changsheng Life
6.2.1 Company Profile
6.2.2 Product Information
6.2.3 Sales, Price, Revenue and Gross Margin
6.3 Zhifei
6.3.1 Company Profile
6.3.2 Product Information
6.3.3 Sales, Price, Revenue and Gross Margin
6.4 ChengDa Bio
6.4.1 Company Profile
6.4.2 Product Information
6.4.3 Sales, Price, Revenue and Gross Margin
6.5 Kangtai
6.5.1 Company Profile
6.5.2 Product Information
6.5.3 Sales, Price, Revenue and Gross Margin
6.6 SINOVAC BIOTECH
6.6.1 Company Profile
6.6.2 Product Information
6.6.3 Sales, Price, Revenue and Gross Margin
6.7 Hissen
6.7.1 Company Profile
6.7.2 Product Information
6.7.3 Sales, Price, Revenue and Gross Margin
6.8 Walvax Biotechnology
6.8.1 Company Profile
6.8.2 Product Information
6.8.3 Sales, Price, Revenue and Gross Margin
6.9 GSK
6.9.1 Company Profile
6.9.2 Product Information
6.9.3 Sales, Price, Revenue and Gross Margin
6.10 SANOFI
6.10.1 Company Profile
6.10.2 Product Information
6.10.3 Sales, Price, Revenue and Gross Margin
6.11 Rong An
6.11.1 Company Profile
6.11.2 Product Information
6.11.3 Sales, Price, Revenue and Gross Margin
6.12 NuoCheng Bio
6.12.1 Company Profile
6.12.2 Product Information
6.12.3 Sales, Price, Revenue and Gross Margin
6.13 Hualan Bio
6.13.1 Company Profile
6.13.2 Product Information
6.13.3 Sales, Price, Revenue and Gross Margin
6.14 Tiantan biological
6.14.1 Company Profile
6.14.2 Product Information
6.14.3 Sales, Price, Revenue and Gross Margin
6.15 Changchun Baike
6.15.1 Company Profile
6.15.2 Product Information
6.15.3 Sales, Price, Revenue and Gross Margin
6.16 Adimmune
6.16.1 Company Profile
6.16.2 Product Information
6.16.3 Sales, Price, Revenue and Gross Margin
6.17 Zhongyianke Biotech
6.17.1 Company Profile
6.17.2 Product Information
6.17.3 Sales, Price, Revenue and Gross Margin
7 Human Vaccine Manufacturing Cost Analysis
7.1 Human Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Other Costs Analysis
7.2.4 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Human Vaccine
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Human Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
10 Market Effect Factors Analysis
10.1 News in Related Industies
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 China Human Vaccine Market Size (Sales and Revenue) Forecast (2019-2025)
11.1 China Human Vaccine Sales, Revenue Forecast (2019-2025)
11.2 China Human Vaccine Sales Forecast by Type (2019-2025)
11.3 China Human Vaccine Sales Forecast by Application (2019-2025)
11.4 China Human Vaccine Sales Forecast by Regions (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
List of Tables and Figures
Figure Product Picture of Human Vaccine
Table China Human Vaccine Sales (M Dose) and Growth Rate (%) Comparison by Types (Product Category) (2013-2025)
Figure China Human Vaccine Sales Volume Market Share by Types in 2017
Figure Product Picture of Varicella
Figure Product Picture of Influenza
Figure Product Picture of Polio
Figure Product Picture of Hepatitis A
Figure Product Picture of Rabies
Figure Product Picture of BCG
Figure Product Picture of Hepatitis B
Figure Product Picture of Pertussis
Figure Product Picture of Pneumococcal
Figure Rota Vaccine Product Picture
Table China Human Vaccine Sales (M Dose) Comparison by Applications (2013-2025)
Figure China Sales Market Share (%) of Human Vaccine by Applications in 2017
Figure Adults Examples
Figure Children Examples
Table China Human Vaccine Market Size (M USD) Comparison by Region (2013-2025)
Figure South China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure East China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure Southwest China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure Northeast China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure North China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure Central China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure Northwest China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Figure China Human Vaccine Sales (M Dose) and Growth Rate (%) (2013-2025)
Figure China Human Vaccine Revenue (M USD) and Growth Rate (2013-2025)
Table China Human Vaccine Sales (M Doses) of Key Players/Manufacturers (2017-2018)
Table China Human Vaccine Sales Share (%) by Players/Manufacturers (2017-2018)
Figure 2017 China Human Vaccine Sales Share (%) by Players/Manufacturers
Figure 2018 China Human Vaccine Sales Share (%) by Players/Manufacturers
Table China Human Vaccine Revenue (M USD) by Players/Manufacturers (2017-2018)
Table China Human Vaccine Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure 2018 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers
Table China Market Human Vaccine Average Price (USD/Doses) of Key Players/Manufacturers (2013-2018)
Figure China Market Human Vaccine Average Price of Key Players/Manufacturers in 2017
Figure 2017 China Human Vaccine Revenue Market Share (%) by Players/Manufacturers
Figure China Human Vaccine Market Share of Top 5 Players/Manufacturers
Figure China Human Vaccine Market Share of Top 10 Players/Manufacturers
Table Mergers & Acquisitions, Expansion in China Market
Table China Players/Manufacturers Human Vaccine Headquarters and Established Data
Table China Human Vaccine Sales (M Dose) by Regions (2013-2018)
Table China Human Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Human Vaccine Sales Share (%) by Regions (2013-2018)
Figure China Human Vaccine Sales Market Share (%) by Regions in 2017
Table China Human Vaccine Revenue (M USD) and Market Share by Regions (2013-2018)
Table China Human Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Human Vaccine Revenue Market Share (%) by Regions (2013-2018)
Figure China Human Vaccine Revenue Market Share (%) by Regions in 2017
Table China Human Vaccine Price (USD/Dose) by Regions (2013-2018)
Table China Human Vaccine Sales (M Dose) by Type (2013-2018)
Table China Human Vaccine Sales Share (%) by Type (2013-2018)
Figure China Human Vaccine Sales Share (%) by Type (2013-2018)
Figure China Human Vaccine Sales Market Share (%) by Type in 2017
Table China Human Vaccine Revenue (M USD) and Market Share by Type (2013-2018)
Table China Human Vaccine Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Human Vaccine by Type (2013-2018)
Figure Revenue Market Share of Human Vaccine by Type in 2017
Table China Human Vaccine Price (USD/Dose) by Types (2013-2018)
Figure China Human Vaccine Sales Growth Rate by Type (2013-2018)
Table China Human Vaccine Sales (M Dose) by Applications (2013-2018)
Table China Human Vaccine Sales Market Share (%) by Applications (2013-2018)
Figure China Human Vaccine Sales Market Share (%) by Applications (2013-2018)
Figure China Human Vaccine Sales Market Share (%) by Applications in 2017
Table China Human Vaccine Sales Growth Rate by Applications (2013-2018)
Figure China Human Vaccine Sales Growth Rate (%) by Applications (2013-2018)
Table CNBG Company Profile
Figure Human Vaccine Product Picture of CNBG
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of CNBG 2017-2018
Table Changsheng Life Company Profile
Figure Human Vaccine Product Picture of Changsheng Life
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Changsheng Life 2017-2018
Table Zhifei Company Profile
Figure Human Vaccine Product Picture of Zhifei
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Zhifei 2017-2018
Table ChengDa Bio Company Profile
Figure Human Vaccine Product Picture of ChengDa Bio
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of ChengDa Bio 2017-2018
Table Kangtai Company Profile
Figure Human Vaccine Product Picture of Kangtai
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Kangtai 2017-2018
Table SINOVAC BIOTECH Company Profile
Figure Human Vaccine Product Picture of SINOVAC BIOTECH
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SINOVAC BIOTECH 2017-2018
Table Hissen Company Profile
Figure Human Vaccine Product Picture of Hissen
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Hissen 2017-2018
Table Walvax Biotechnology Company Profile
Figure Human Vaccine Product Picture of Walvax Biotechnology
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Walvax Biotechnology 2017-2018
Table GSK Company Profile
Figure Human Vaccine Product Picture of GSK
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of GSK 2017-2018
Table SANOFI Company Profile
Figure Human Vaccine Product Picture of SANOFI
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of SANOFI 2017-2018
Table Rong An Company Profile
Figure Human Vaccine Product Picture of Rong An
Table Human Vaccine Sales (M Doses), Price (USD/Dose), Revenue (M USD) and Gross Margin of Rong An 2017-2018
Table NuoCheng Bio Company Profile
Figure Human Vaccine Product Picture of NuoCheng Bio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook